Latest News about BMY
Recent news which mentions BMY
2 Top Biotech Stocks To Buy Right Now
December 13, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
From Benzinga
Here’s a list of favored dividend stocks with room to pay more for investors worried about 2022
December 10, 2021
From MarketWatch
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
From Motley Fool
3 Beaten-Down Dividend Stocks -- Are They Bargins Now?
December 06, 2021
From Motley Fool
Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?
December 04, 2021
From Motley Fool
Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
2 Absurdly Cheap Growth Stocks to Buy in December
December 03, 2021
From Motley Fool
5 Warren Buffett Stocks Are Screaming Buys in December
December 03, 2021
From Motley Fool
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
From InvestorPlace
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
Will Moderna Become the Next Big Meme Stock?
December 01, 2021
From Motley Fool
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
Mereo BioPharma's Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical Cancer
November 30, 2021
From Benzinga
Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb
November 30, 2021
From Motley Fool
Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More
November 30, 2021
From Benzinga
Is This Leading COVID Stock a Buy Right Now?
November 30, 2021
From Motley Fool
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
November 29, 2021
From Benzinga
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
From Motley Fool
3 Surefire Winning Stocks to Buy If There's a Stock Market Crash
November 27, 2021
From Motley Fool
5 Stocks Insiders Are Selling
November 26, 2021
From Benzinga
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
From Motley Fool
Bristol Myers' Zeposia Wins European Approval For Ulcerative Colitis
November 23, 2021
Tickers
BMY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.